A randomised controlled trial of cannabidiol (CBD) in the treatment of cannabis dependence

  • Lintzeris, Nicholas (Primary Chief Investigator (PCI))
  • Lubman, Dan (Chief Investigator (CI))
  • Doyle, Michael Francis (Chief Investigator (CI))
  • Dunlop, Adrian John (Chief Investigator (CI))
  • Mills, Llewellyn (Chief Investigator (CI))
  • Harrod, Mary (Chief Investigator (CI))
  • Arunogiri, Shalini (Chief Investigator (CI))
  • Malouf, Peter (Chief Investigator (CI))
  • Haber, Paul Steven (Chief Investigator (CI))
  • Freeman, Tom (Chief Investigator (CI))
  • Solowij, Nadia (Associate Investigator (AI))
  • Graham, Robert (Associate Investigator (AI))
  • Childs, Steven (Associate Investigator (AI))
  • Ella, Steve (Associate Investigator (AI))
  • Montebello, Mark (Associate Investigator (AI))
  • Nean, Martin (Associate Investigator (AI))
  • Galettis, Peter (Associate Investigator (AI))
  • Reeves, Penny (Associate Investigator (AI))
  • Monds, Lauren Ann (Associate Investigator (AI))
  • Jefferies, Meryem (Associate Investigator (AI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/22 → 30/06/25

Funding

  • NHMRC - National Health and Medical Research Council (Australia): A$2,120,137.80

Keywords

  • cannabis
  • substance use disorder
  • addiction treatment